Use Of Hydroxyurea For Sickle Cell Disease In An Academic Center

被引：0
|
作者：
Gowhari, Michel
Abbasi, Taimur
Machado, Roberto F.
Gordeuk, Victor R.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.4697.4697
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4697
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hydroxyurea use in young infants with sickle cell disease
    Schuchard, Sarah B.
    Lissick, Jennifer R.
    Nickel, Amanda
    Watson, David
    Moquist, Kristin L.
    Blaylark, Rae M.
    Nelson, Stephen C.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [2] Predictors of Hydroxyurea Use in Children with Sickle Cell Disease
    Okwor, Chisom Ifeoma
    Klaassen, Robert J.
    Harrison, Mary-Ann
    Tang, Ken
    Laforest, Isabelle
    Bowerman, Brooke
    Simpson, Ewurabena
    BLOOD, 2018, 132
  • [3] Hydroxyurea Use and Outcomes of Pregnancy in Sickle Cell Disease
    Gordeuk, Victor R.
    Kroner, Barbara
    Pugh, Norma
    Hankins, Jane S.
    Kutlar, Abdullah
    King, Allison A.
    Shah, Nirmish
    Kanter, Julie
    Glassberg, Jeffrey
    Treadwell, Marsha
    BLOOD, 2020, 136
  • [4] Update on the use of hydroxyurea therapy in sickle cell disease
    Wong, Trisha E.
    Brandow, Amanda M.
    Lim, Wendy
    Lottenberg, Richard
    BLOOD, 2014, 124 (26) : 3850 - 3857
  • [5] Hydroxyurea in sickle cell disease
    Schechter, AN
    Rodgers, GP
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05): : 333 - 333
  • [6] Use of hydroxyurea in prevention of stroke in children with sickle cell disease
    Lefevre, Nicolas
    Dufour, Dominique
    Gulbis, Beatrice
    Le, Phu-Quoc
    Heijmans, Catherine
    Ferster, Alina
    BLOOD, 2008, 111 (02) : 963 - 964
  • [7] Experts urge wider use of hydroxyurea of sickle cell disease
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (07) : 592 - 593
  • [8] Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
    Wong, Trisha E.
    Valle, Jhaqueline
    Paulukonis, Susan
    HEALTH SCIENCE REPORTS, 2021, 4 (03)
  • [9] Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria
    Adeyemo, Titilope A.
    Diaku-Akinwunmi, Ijeoma N.
    Ojewunmi, Oyesola O.
    Bolarinwa, Abiola B.
    Adekile, Adekunle D.
    HEMOGLOBIN, 2019, 43 (03) : 188 - 192
  • [10] On the use of hydroxyurea erythropoietin combination therapy for sickle cell disease
    ElHazmi, MAF
    AlMomen, A
    Kandaswamy, S
    Huraib, S
    Harakati, M
    AlMohareb, F
    Warsy, AS
    ACTA HAEMATOLOGICA, 1995, 94 (03) : 128 - 134
12345